Biogen (BIIB) Initiates Late-Stage Study on Lupus Candidate

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jun 21, 2021 at 11:02 AM.

  1. #1 cafead, Jun 21, 2021 at 11:02 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,930
    Likes Received:
    3
    via Biogen Inc. BIIB announced that it has dosed the first patient in the phase III study — TOPAZ-1 — that will evaluate its humanized IgG1 monoclonal antibody (mAb) candidate, BIIB059, in patients with active systemic lupus erythematosus (SLE).

    article source
     
    Quote

Reply to Thread